Viewing Study NCT05038020


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-01-29 @ 3:06 PM
Study NCT ID: NCT05038020
Status: TERMINATED
Last Update Posted: 2023-11-01
First Post: 2021-07-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)
Sponsor: Alkahest, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Retinopathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CCR3 inhibition View
None Diabetic Retinopathy View
None Oral Treatment View